TAYLOR SCHUB: Open Payments
NPI 1023638244 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 7 companies in 2025. Trend: 2023 $150 · 2024 $116 · 2025 $275
Food & beverage: $176Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $148 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $34 |
| Biogen, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: Veozah, ZURZUVAE, Mirena, GARDASIL 9, ABRYSVO, SLYND.
Industry payments across IN — which companies pay providers there.
